Leber's hereditary optic neuropathy (LHON), which is associated with mutations in mitochondrial DNA (mtDNA), is commoner in males than females. A study of over 30 LHON families with a mutation at position 3460 of mtDNA demonstrates a significantly decreased male excess from that generally quoted, with evidence for a marked bias in the ascertainment of males over females. This has implications for the analysis of those factors which give rise to the male bias.
inheritance; other factors, either genetic or environ mental, also appear to influence the phenotype.
Data presented here suggest that the sex distribu tion varies for the different mitochondrial mutations. Furthermore, there is evidence for a clinical bias towards diagnosing LHON in males.
METHODS

Preparation of Genomic DNA
DNA from peripheral blood was extracted by standard procedures. 9 Where we were unable to obtain blood from individuals of family L2, DNA was extracted from buccal mouthwashes. 1°
Mutation Analysis
Polymerase chain reaction (peR) was carried out in 50 f-ll reaction volumes overlaid with paraffin oil. The reaction mix consisted of 100-200 ng of genomic DNA, 0.5-1 f-lM of each primer, 5 f-ll of Boehringer lOx concentration reaction buffer, 0.2 mM of each dNTP and 0.25 f-ll of Taq polymerase (Boehringer). Samples were processed through 29 cycles of denaturation (94°C for 60 seconds), annealing (55°C for 60 seconds) and elongation (74 °e for 1 minute).
The primers, according to position on the mtDNA, were 3275-3295 (forward) and 3557-3577 (reverse). A product of 302 base pairs is amplified, and the 3460 ND1 mutation, G2 -A, removes a BsaH1 (New England Biolabs) restriction enzyme site, which, when cleaved, produces fragments of 117 and 185 base pairs. The fragments were resolved on a 2 % agarose gel, and stained with ethidium bromide and photographed.
MtDNA Analysis
The mtDNA point mutations at positions 4216, 11 778, 13 708, 15 257 and 15 812 were screened for by PCR using the conditions described above. Primer positions and restriction site analysis are given in Table I . (Fig. 1) have the 3460 mutation and are wild-type at positions 4216, 11 778, 13 708, 15 257 and 15 812. Of a total of 70 individuals related to the maternal lines (33 female and 37 male), 31 (44%) were clinically affected. Of these, 22 were male (71 %) and 9 female (29%). Because the sex distribution for these families differs from that generally quoted we compiled data on the distribu tion between the sexes for as many 3460 patients as possible (Table II) .
RESULTS
Both new families investigated
These data give ratios of 3.66: 1 (77.2% males) for those with classical disease or, including those with peripapillary micrangiopathy (the second figure), 3.03 : 1 (75.2% males). These figures are similar to those seen for the two families discussed above. Combining the data in Table II with those from the families shown in Fig. 1 , for all those affected with classical LHON, gives 119 males and 37 females -a ratio of 3.22 : 1 (76.2% males) amongst 33 families. 
DISCUSSION
The data presented here suggest that the observed s ex distribution in families, both published and unpublished, carrying the 3460 mutation is around 3 : 1 (males : females). Interestingly, 12 of the families contain only one affected member, and of these only one is female. This suggests considerable clinical bias towards males in the diagnosis of sporadic cases of LHON. In order to minimise this bias, the singleton families were excluded from the analysis to give a ratio of 2.97 : 1. This differs significantly (p<0.00l) from that generally quoted (i.e. 85% or 5.66 : 1) and is likely to reflect the true d i stribution for the 3460 mutation.
Although life style and/or physiological differences might be invoked, an X-linked recessive factor interacting with mitochondrially encoded factors would be an attractive hypothesis to explain the observed sex ratio Y However, several studies have failed to demonstrate linkage to any region of the X chromosome p -15 We suggest that these studies are inconclusive and have not ruled out an X-linked susceptibility locus. There is mounting evidence that multiple predisposing factors are involved in the aetiology of LHON. The following might therefore confound such analysis and conceal linkage.
Incorrect estimations of penetrance may have a profound effect on the evaluation of linkage data. As LHON may manifest at any time between the ages of 10 and 65 years, only a small number of relatives can confidently be classified as unaffected.
Tissue-specific factors may be directly relevant to the manifestation of the disease, but must be studied indirectly as the optic nerve can only be sampled post-mortem. These include mtDNA heteroplasmy and, if an X-linked factor is involved, the X inactivation patterns of females.
Furthermore, recent evidence suggests that certain mtDNA 'polymorphisms' might affect the pheno type, perhaps in a cumulative fashion. 1 6 Thus defining truly homogeneous groups may as yet be impossible. Our data show that the sex distribution for the 3460 mutation differs from other groups of LHON. This strongly suggests that the influence of the predisposing factors varies according to their interaction with the different mtDNA mutations. Thus families with different mitochondrial mutations should not be grouped together for linkage analysis.
Lastly, in the case of other X-linked ocular diseases, such as X-linked retinitis pigmentosa, distinct loci have been shown to cause similar diseases 17 -there might be more than one nuclear/ X-linked factor involved.
Thus conventional genetic analysis might well fail to demonstrate linkage to regions which nevertheless are involved in the disease. Such analysis may th erefore be inappropriate for the identification of any interacting nuclear gene. The existence of an X linked susceptibility gene remains a plausible hypothesis. A more fruitful approach might be to look at the co-segregation of candidate nuclear genes which are known to interact with the mitochondrion. Examples include the pyruvate dehydrogenase subunit E1a and a possible X-linked locus that complements defects in complex I of the electron transport chain and which has been described in mouse-hamster hybrids. 1 8 Characterisation of such a locus would represent an interesting starting point for study.
